CVS Health Corporation (NEO:CVS)

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of CAD 142.46 billion. The enterprise value is 241.81 billion.

Market Cap	142.46B
Enterprise Value	241.81B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.56%
Float	1.27B

Valuation Ratios

The trailing PE ratio is 218.07 and the forward PE ratio is 11.48.

PE Ratio	218.07
Forward PE	11.48
PS Ratio	0.26
PB Ratio	1.40
P/TBV Ratio	n/a
P/FCF Ratio	16.25
P/OCF Ratio	11.23
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.72, with an EV/FCF ratio of 27.59.

EV / Earnings	370.16
EV / Sales	0.44
EV / EBITDA	9.72
EV / EBIT	16.96
EV / FCF	27.59

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.12.

Current Ratio	0.83
Quick Ratio	0.59
Debt / Equity	1.12
Debt / EBITDA	4.62
Debt / FCF	12.99
Interest Coverage	3.28

Financial Efficiency

Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 4.06%.

Return on Equity (ROE)	0.58%
Return on Assets (ROA)	2.50%
Return on Invested Capital (ROIC)	4.06%
Return on Capital Employed (ROCE)	6.24%
Revenue Per Employee	2.10M
Profits Per Employee	2,517
Employee Count	300,000
Asset Turnover	1.54
Inventory Turnover	18.54

Taxes

In the past 12 months, CVS Health has paid 3.45 billion in taxes.

Income Tax	3.45B
Effective Tax Rate	85.28%

Stock Price Statistics

The stock price has increased by +30.05% in the last 52 weeks. The beta is 0.48, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+30.05%
50-Day Moving Average	19.09
200-Day Moving Average	16.92
Relative Strength Index (RSI)	55.85
Average Volume (20 Days)	4,792

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.57

Income Statement

In the last 12 months, CVS Health had revenue of CAD 545.58 billion and earned 653.27 million in profits. Earnings per share was 0.52.

Revenue	545.58B
Gross Profit	72.85B
Operating Income	14.13B
Pretax Income	4.05B
Net Income	653.27M
EBITDA	20.55B
EBIT	14.13B
Earnings Per Share (EPS)	0.52

Balance Sheet

The company has 15.64 billion in cash and 113.87 billion in debt, giving a net cash position of -98.23 billion.

Cash & Cash Equivalents	15.64B
Total Debt	113.87B
Net Cash	-98.23B
Net Cash Per Share	n/a
Equity (Book Value)	101.83B
Book Value Per Share	79.98
Working Capital	-21.71B

Cash Flow

In the last 12 months, operating cash flow was 12.69 billion and capital expenditures -3.92 billion, giving a free cash flow of 8.77 billion.

Operating Cash Flow	12.69B
Capital Expenditures	-3.92B
Free Cash Flow	8.77B
FCF Per Share	n/a

Margins

Gross margin is 13.35%, with operating and profit margins of 2.59% and 0.12%.

Gross Margin	13.35%
Operating Margin	2.59%
Pretax Margin	0.74%
Profit Margin	0.12%
EBITDA Margin	3.77%
EBIT Margin	2.59%
FCF Margin	1.61%

Dividends & Yields

CVS Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	722.81%
Buyback Yield	0.37%
Shareholder Yield	0.37%
Earnings Yield	0.46%
FCF Yield	6.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.18
Piotroski F-Score	6